[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Bacteria-derived Microbial Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

June 2024 | 136 pages | ID: G1E1A8E1A48EEN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Bacteria-derived Microbial Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

The Global Info Research report includes an overview of the development of the Bacteria-derived Microbial Drugs industry chain, the market status of Gastrointestinal Disorders (Oral Dosage Form, Enteric Capsules), Autoimmune Disorders (Oral Dosage Form, Enteric Capsules), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Bacteria-derived Microbial Drugs.

Regionally, the report analyzes the Bacteria-derived Microbial Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Bacteria-derived Microbial Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the Bacteria-derived Microbial Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Bacteria-derived Microbial Drugs industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Oral Dosage Form, Enteric Capsules).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Bacteria-derived Microbial Drugs market.

Regional Analysis: The report involves examining the Bacteria-derived Microbial Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Bacteria-derived Microbial Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Bacteria-derived Microbial Drugs:

Company Analysis: Report covers individual Bacteria-derived Microbial Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Bacteria-derived Microbial Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Gastrointestinal Disorders, Autoimmune Disorders).

Technology Analysis: Report covers specific technologies relevant to Bacteria-derived Microbial Drugs. It assesses the current state, advancements, and potential future developments in Bacteria-derived Microbial Drugs areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Bacteria-derived Microbial Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation

Bacteria-derived Microbial Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
  • Oral Dosage Form
  • Enteric Capsules
Market segment by Application
  • Gastrointestinal Disorders
  • Autoimmune Disorders
  • Diabetes
  • Cancer
  • Others
Major players covered
  • Seres Therapeutics
  • Assembly Biosciences
  • Synthetic Biologics
  • Interxon
  • PureTech
  • Synlogic
  • Enterome BioScience
  • 4D Pharma
  • Second Genome
  • AOBiome
  • Rebiotix
  • Metabiomics
  • Ritter Pharmaceuticals
  • Symberix
  • OpenBiome
  • Azitra
  • Osel
Market segment by region, regional analysis covers
  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Bacteria-derived Microbial Drugs product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Bacteria-derived Microbial Drugs, with price, sales, revenue and global market share of Bacteria-derived Microbial Drugs from 2019 to 2024.

Chapter 3, the Bacteria-derived Microbial Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Bacteria-derived Microbial Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Bacteria-derived Microbial Drugs market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Bacteria-derived Microbial Drugs.

Chapter 14 and 15, to describe Bacteria-derived Microbial Drugs sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope of Bacteria-derived Microbial Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
  1.3.1 Overview: Global Bacteria-derived Microbial Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
  1.3.2 Oral Dosage Form
  1.3.3 Enteric Capsules
1.4 Market Analysis by Application
  1.4.1 Overview: Global Bacteria-derived Microbial Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
  1.4.2 Gastrointestinal Disorders
  1.4.3 Autoimmune Disorders
  1.4.4 Diabetes
  1.4.5 Cancer
  1.4.6 Others
1.5 Global Bacteria-derived Microbial Drugs Market Size & Forecast
  1.5.1 Global Bacteria-derived Microbial Drugs Consumption Value (2019 & 2023 & 2030)
  1.5.2 Global Bacteria-derived Microbial Drugs Sales Quantity (2019-2030)
  1.5.3 Global Bacteria-derived Microbial Drugs Average Price (2019-2030)

2 MANUFACTURERS PROFILES

2.1 Seres Therapeutics
  2.1.1 Seres Therapeutics Details
  2.1.2 Seres Therapeutics Major Business
  2.1.3 Seres Therapeutics Bacteria-derived Microbial Drugs Product and Services
  2.1.4 Seres Therapeutics Bacteria-derived Microbial Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.1.5 Seres Therapeutics Recent Developments/Updates
2.2 Assembly Biosciences
  2.2.1 Assembly Biosciences Details
  2.2.2 Assembly Biosciences Major Business
  2.2.3 Assembly Biosciences Bacteria-derived Microbial Drugs Product and Services
  2.2.4 Assembly Biosciences Bacteria-derived Microbial Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.2.5 Assembly Biosciences Recent Developments/Updates
2.3 Synthetic Biologics
  2.3.1 Synthetic Biologics Details
  2.3.2 Synthetic Biologics Major Business
  2.3.3 Synthetic Biologics Bacteria-derived Microbial Drugs Product and Services
  2.3.4 Synthetic Biologics Bacteria-derived Microbial Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.3.5 Synthetic Biologics Recent Developments/Updates
2.4 Interxon
  2.4.1 Interxon Details
  2.4.2 Interxon Major Business
  2.4.3 Interxon Bacteria-derived Microbial Drugs Product and Services
  2.4.4 Interxon Bacteria-derived Microbial Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.4.5 Interxon Recent Developments/Updates
2.5 PureTech
  2.5.1 PureTech Details
  2.5.2 PureTech Major Business
  2.5.3 PureTech Bacteria-derived Microbial Drugs Product and Services
  2.5.4 PureTech Bacteria-derived Microbial Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.5.5 PureTech Recent Developments/Updates
2.6 Synlogic
  2.6.1 Synlogic Details
  2.6.2 Synlogic Major Business
  2.6.3 Synlogic Bacteria-derived Microbial Drugs Product and Services
  2.6.4 Synlogic Bacteria-derived Microbial Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.6.5 Synlogic Recent Developments/Updates
2.7 Enterome BioScience
  2.7.1 Enterome BioScience Details
  2.7.2 Enterome BioScience Major Business
  2.7.3 Enterome BioScience Bacteria-derived Microbial Drugs Product and Services
  2.7.4 Enterome BioScience Bacteria-derived Microbial Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.7.5 Enterome BioScience Recent Developments/Updates
2.8 4D Pharma
  2.8.1 4D Pharma Details
  2.8.2 4D Pharma Major Business
  2.8.3 4D Pharma Bacteria-derived Microbial Drugs Product and Services
  2.8.4 4D Pharma Bacteria-derived Microbial Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.8.5 4D Pharma Recent Developments/Updates
2.9 Second Genome
  2.9.1 Second Genome Details
  2.9.2 Second Genome Major Business
  2.9.3 Second Genome Bacteria-derived Microbial Drugs Product and Services
  2.9.4 Second Genome Bacteria-derived Microbial Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.9.5 Second Genome Recent Developments/Updates
2.10 AOBiome
  2.10.1 AOBiome Details
  2.10.2 AOBiome Major Business
  2.10.3 AOBiome Bacteria-derived Microbial Drugs Product and Services
  2.10.4 AOBiome Bacteria-derived Microbial Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.10.5 AOBiome Recent Developments/Updates
2.11 Rebiotix
  2.11.1 Rebiotix Details
  2.11.2 Rebiotix Major Business
  2.11.3 Rebiotix Bacteria-derived Microbial Drugs Product and Services
  2.11.4 Rebiotix Bacteria-derived Microbial Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.11.5 Rebiotix Recent Developments/Updates
2.12 Metabiomics
  2.12.1 Metabiomics Details
  2.12.2 Metabiomics Major Business
  2.12.3 Metabiomics Bacteria-derived Microbial Drugs Product and Services
  2.12.4 Metabiomics Bacteria-derived Microbial Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.12.5 Metabiomics Recent Developments/Updates
2.13 Ritter Pharmaceuticals
  2.13.1 Ritter Pharmaceuticals Details
  2.13.2 Ritter Pharmaceuticals Major Business
  2.13.3 Ritter Pharmaceuticals Bacteria-derived Microbial Drugs Product and Services
  2.13.4 Ritter Pharmaceuticals Bacteria-derived Microbial Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.13.5 Ritter Pharmaceuticals Recent Developments/Updates
2.14 Symberix
  2.14.1 Symberix Details
  2.14.2 Symberix Major Business
  2.14.3 Symberix Bacteria-derived Microbial Drugs Product and Services
  2.14.4 Symberix Bacteria-derived Microbial Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.14.5 Symberix Recent Developments/Updates
2.15 OpenBiome
  2.15.1 OpenBiome Details
  2.15.2 OpenBiome Major Business
  2.15.3 OpenBiome Bacteria-derived Microbial Drugs Product and Services
  2.15.4 OpenBiome Bacteria-derived Microbial Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.15.5 OpenBiome Recent Developments/Updates
2.16 Azitra
  2.16.1 Azitra Details
  2.16.2 Azitra Major Business
  2.16.3 Azitra Bacteria-derived Microbial Drugs Product and Services
  2.16.4 Azitra Bacteria-derived Microbial Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.16.5 Azitra Recent Developments/Updates
2.17 Osel
  2.17.1 Osel Details
  2.17.2 Osel Major Business
  2.17.3 Osel Bacteria-derived Microbial Drugs Product and Services
  2.17.4 Osel Bacteria-derived Microbial Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.17.5 Osel Recent Developments/Updates

3 COMPETITIVE ENVIRONMENT: BACTERIA-DERIVED MICROBIAL DRUGS BY MANUFACTURER

3.1 Global Bacteria-derived Microbial Drugs Sales Quantity by Manufacturer (2019-2024)
3.2 Global Bacteria-derived Microbial Drugs Revenue by Manufacturer (2019-2024)
3.3 Global Bacteria-derived Microbial Drugs Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
  3.4.1 Producer Shipments of Bacteria-derived Microbial Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
  3.4.2 Top 3 Bacteria-derived Microbial Drugs Manufacturer Market Share in 2023
  3.4.2 Top 6 Bacteria-derived Microbial Drugs Manufacturer Market Share in 2023
3.5 Bacteria-derived Microbial Drugs Market: Overall Company Footprint Analysis
  3.5.1 Bacteria-derived Microbial Drugs Market: Region Footprint
  3.5.2 Bacteria-derived Microbial Drugs Market: Company Product Type Footprint
  3.5.3 Bacteria-derived Microbial Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 CONSUMPTION ANALYSIS BY REGION

4.1 Global Bacteria-derived Microbial Drugs Market Size by Region
  4.1.1 Global Bacteria-derived Microbial Drugs Sales Quantity by Region (2019-2030)
  4.1.2 Global Bacteria-derived Microbial Drugs Consumption Value by Region (2019-2030)
  4.1.3 Global Bacteria-derived Microbial Drugs Average Price by Region (2019-2030)
4.2 North America Bacteria-derived Microbial Drugs Consumption Value (2019-2030)
4.3 Europe Bacteria-derived Microbial Drugs Consumption Value (2019-2030)
4.4 Asia-Pacific Bacteria-derived Microbial Drugs Consumption Value (2019-2030)
4.5 South America Bacteria-derived Microbial Drugs Consumption Value (2019-2030)
4.6 Middle East and Africa Bacteria-derived Microbial Drugs Consumption Value (2019-2030)

5 MARKET SEGMENT BY TYPE

5.1 Global Bacteria-derived Microbial Drugs Sales Quantity by Type (2019-2030)
5.2 Global Bacteria-derived Microbial Drugs Consumption Value by Type (2019-2030)
5.3 Global Bacteria-derived Microbial Drugs Average Price by Type (2019-2030)

6 MARKET SEGMENT BY APPLICATION

6.1 Global Bacteria-derived Microbial Drugs Sales Quantity by Application (2019-2030)
6.2 Global Bacteria-derived Microbial Drugs Consumption Value by Application (2019-2030)
6.3 Global Bacteria-derived Microbial Drugs Average Price by Application (2019-2030)

7 NORTH AMERICA

7.1 North America Bacteria-derived Microbial Drugs Sales Quantity by Type (2019-2030)
7.2 North America Bacteria-derived Microbial Drugs Sales Quantity by Application (2019-2030)
7.3 North America Bacteria-derived Microbial Drugs Market Size by Country
  7.3.1 North America Bacteria-derived Microbial Drugs Sales Quantity by Country (2019-2030)
  7.3.2 North America Bacteria-derived Microbial Drugs Consumption Value by Country (2019-2030)
  7.3.3 United States Market Size and Forecast (2019-2030)
  7.3.4 Canada Market Size and Forecast (2019-2030)
  7.3.5 Mexico Market Size and Forecast (2019-2030)

8 EUROPE

8.1 Europe Bacteria-derived Microbial Drugs Sales Quantity by Type (2019-2030)
8.2 Europe Bacteria-derived Microbial Drugs Sales Quantity by Application (2019-2030)
8.3 Europe Bacteria-derived Microbial Drugs Market Size by Country
  8.3.1 Europe Bacteria-derived Microbial Drugs Sales Quantity by Country (2019-2030)
  8.3.2 Europe Bacteria-derived Microbial Drugs Consumption Value by Country (2019-2030)
  8.3.3 Germany Market Size and Forecast (2019-2030)
  8.3.4 France Market Size and Forecast (2019-2030)
  8.3.5 United Kingdom Market Size and Forecast (2019-2030)
  8.3.6 Russia Market Size and Forecast (2019-2030)
  8.3.7 Italy Market Size and Forecast (2019-2030)

9 ASIA-PACIFIC

9.1 Asia-Pacific Bacteria-derived Microbial Drugs Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Bacteria-derived Microbial Drugs Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Bacteria-derived Microbial Drugs Market Size by Region
  9.3.1 Asia-Pacific Bacteria-derived Microbial Drugs Sales Quantity by Region (2019-2030)
  9.3.2 Asia-Pacific Bacteria-derived Microbial Drugs Consumption Value by Region (2019-2030)
  9.3.3 China Market Size and Forecast (2019-2030)
  9.3.4 Japan Market Size and Forecast (2019-2030)
  9.3.5 Korea Market Size and Forecast (2019-2030)
  9.3.6 India Market Size and Forecast (2019-2030)
  9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
  9.3.8 Australia Market Size and Forecast (2019-2030)

10 SOUTH AMERICA

10.1 South America Bacteria-derived Microbial Drugs Sales Quantity by Type (2019-2030)
10.2 South America Bacteria-derived Microbial Drugs Sales Quantity by Application (2019-2030)
10.3 South America Bacteria-derived Microbial Drugs Market Size by Country
  10.3.1 South America Bacteria-derived Microbial Drugs Sales Quantity by Country (2019-2030)
  10.3.2 South America Bacteria-derived Microbial Drugs Consumption Value by Country (2019-2030)
  10.3.3 Brazil Market Size and Forecast (2019-2030)
  10.3.4 Argentina Market Size and Forecast (2019-2030)

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Bacteria-derived Microbial Drugs Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Bacteria-derived Microbial Drugs Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Bacteria-derived Microbial Drugs Market Size by Country
  11.3.1 Middle East & Africa Bacteria-derived Microbial Drugs Sales Quantity by Country (2019-2030)
  11.3.2 Middle East & Africa Bacteria-derived Microbial Drugs Consumption Value by Country (2019-2030)
  11.3.3 Turkey Market Size and Forecast (2019-2030)
  11.3.4 Egypt Market Size and Forecast (2019-2030)
  11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
  11.3.6 South Africa Market Size and Forecast (2019-2030)

12 MARKET DYNAMICS

12.1 Bacteria-derived Microbial Drugs Market Drivers
12.2 Bacteria-derived Microbial Drugs Market Restraints
12.3 Bacteria-derived Microbial Drugs Trends Analysis
12.4 Porters Five Forces Analysis
  12.4.1 Threat of New Entrants
  12.4.2 Bargaining Power of Suppliers
  12.4.3 Bargaining Power of Buyers
  12.4.4 Threat of Substitutes
  12.4.5 Competitive Rivalry

13 RAW MATERIAL AND INDUSTRY CHAIN

13.1 Raw Material of Bacteria-derived Microbial Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Bacteria-derived Microbial Drugs
13.3 Bacteria-derived Microbial Drugs Production Process
13.4 Bacteria-derived Microbial Drugs Industrial Chain

14 SHIPMENTS BY DISTRIBUTION CHANNEL

14.1 Sales Channel
  14.1.1 Direct to End-User
  14.1.2 Distributors
14.2 Bacteria-derived Microbial Drugs Typical Distributors
14.3 Bacteria-derived Microbial Drugs Typical Customers

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

LIST OF TABLES

Table 1. Global Bacteria-derived Microbial Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Bacteria-derived Microbial Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Seres Therapeutics Basic Information, Manufacturing Base and Competitors
Table 4. Seres Therapeutics Major Business
Table 5. Seres Therapeutics Bacteria-derived Microbial Drugs Product and Services
Table 6. Seres Therapeutics Bacteria-derived Microbial Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Seres Therapeutics Recent Developments/Updates
Table 8. Assembly Biosciences Basic Information, Manufacturing Base and Competitors
Table 9. Assembly Biosciences Major Business
Table 10. Assembly Biosciences Bacteria-derived Microbial Drugs Product and Services
Table 11. Assembly Biosciences Bacteria-derived Microbial Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Assembly Biosciences Recent Developments/Updates
Table 13. Synthetic Biologics Basic Information, Manufacturing Base and Competitors
Table 14. Synthetic Biologics Major Business
Table 15. Synthetic Biologics Bacteria-derived Microbial Drugs Product and Services
Table 16. Synthetic Biologics Bacteria-derived Microbial Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Synthetic Biologics Recent Developments/Updates
Table 18. Interxon Basic Information, Manufacturing Base and Competitors
Table 19. Interxon Major Business
Table 20. Interxon Bacteria-derived Microbial Drugs Product and Services
Table 21. Interxon Bacteria-derived Microbial Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Interxon Recent Developments/Updates
Table 23. PureTech Basic Information, Manufacturing Base and Competitors
Table 24. PureTech Major Business
Table 25. PureTech Bacteria-derived Microbial Drugs Product and Services
Table 26. PureTech Bacteria-derived Microbial Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. PureTech Recent Developments/Updates
Table 28. Synlogic Basic Information, Manufacturing Base and Competitors
Table 29. Synlogic Major Business
Table 30. Synlogic Bacteria-derived Microbial Drugs Product and Services
Table 31. Synlogic Bacteria-derived Microbial Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Synlogic Recent Developments/Updates
Table 33. Enterome BioScience Basic Information, Manufacturing Base and Competitors
Table 34. Enterome BioScience Major Business
Table 35. Enterome BioScience Bacteria-derived Microbial Drugs Product and Services
Table 36. Enterome BioScience Bacteria-derived Microbial Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Enterome BioScience Recent Developments/Updates
Table 38. 4D Pharma Basic Information, Manufacturing Base and Competitors
Table 39. 4D Pharma Major Business
Table 40. 4D Pharma Bacteria-derived Microbial Drugs Product and Services
Table 41. 4D Pharma Bacteria-derived Microbial Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. 4D Pharma Recent Developments/Updates
Table 43. Second Genome Basic Information, Manufacturing Base and Competitors
Table 44. Second Genome Major Business
Table 45. Second Genome Bacteria-derived Microbial Drugs Product and Services
Table 46. Second Genome Bacteria-derived Microbial Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Second Genome Recent Developments/Updates
Table 48. AOBiome Basic Information, Manufacturing Base and Competitors
Table 49. AOBiome Major Business
Table 50. AOBiome Bacteria-derived Microbial Drugs Product and Services
Table 51. AOBiome Bacteria-derived Microbial Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. AOBiome Recent Developments/Updates
Table 53. Rebiotix Basic Information, Manufacturing Base and Competitors
Table 54. Rebiotix Major Business
Table 55. Rebiotix Bacteria-derived Microbial Drugs Product and Services
Table 56. Rebiotix Bacteria-derived Microbial Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Rebiotix Recent Developments/Updates
Table 58. Metabiomics Basic Information, Manufacturing Base and Competitors
Table 59. Metabiomics Major Business
Table 60. Metabiomics Bacteria-derived Microbial Drugs Product and Services
Table 61. Metabiomics Bacteria-derived Microbial Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Metabiomics Recent Developments/Updates
Table 63. Ritter Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 64. Ritter Pharmaceuticals Major Business
Table 65. Ritter Pharmaceuticals Bacteria-derived Microbial Drugs Product and Services
Table 66. Ritter Pharmaceuticals Bacteria-derived Microbial Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Ritter Pharmaceuticals Recent Developments/Updates
Table 68. Symberix Basic Information, Manufacturing Base and Competitors
Table 69. Symberix Major Business
Table 70. Symberix Bacteria-derived Microbial Drugs Product and Services
Table 71. Symberix Bacteria-derived Microbial Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Symberix Recent Developments/Updates
Table 73. OpenBiome Basic Information, Manufacturing Base and Competitors
Table 74. OpenBiome Major Business
Table 75. OpenBiome Bacteria-derived Microbial Drugs Product and Services
Table 76. OpenBiome Bacteria-derived Microbial Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. OpenBiome Recent Developments/Updates
Table 78. Azitra Basic Information, Manufacturing Base and Competitors
Table 79. Azitra Major Business
Table 80. Azitra Bacteria-derived Microbial Drugs Product and Services
Table 81. Azitra Bacteria-derived Microbial Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Azitra Recent Developments/Updates
Table 83. Osel Basic Information, Manufacturing Base and Competitors
Table 84. Osel Major Business
Table 85. Osel Bacteria-derived Microbial Drugs Product and Services
Table 86. Osel Bacteria-derived Microbial Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 87. Osel Recent Developments/Updates
Table 88. Global Bacteria-derived Microbial Drugs Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 89. Global Bacteria-derived Microbial Drugs Revenue by Manufacturer (2019-2024) & (USD Million)
Table 90. Global Bacteria-derived Microbial Drugs Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 91. Market Position of Manufacturers in Bacteria-derived Microbial Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 92. Head Office and Bacteria-derived Microbial Drugs Production Site of Key Manufacturer
Table 93. Bacteria-derived Microbial Drugs Market: Company Product Type Footprint
Table 94. Bacteria-derived Microbial Drugs Market: Company Product Application Footprint
Table 95. Bacteria-derived Microbial Drugs New Market Entrants and Barriers to Market Entry
Table 96. Bacteria-derived Microbial Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 97. Global Bacteria-derived Microbial Drugs Sales Quantity by Region (2019-2024) & (K Units)
Table 98. Global Bacteria-derived Microbial Drugs Sales Quantity by Region (2025-2030) & (K Units)
Table 99. Global Bacteria-derived Microbial Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 100. Global Bacteria-derived Microbial Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 101. Global Bacteria-derived Microbial Drugs Average Price by Region (2019-2024) & (US$/Unit)
Table 102. Global Bacteria-derived Microbial Drugs Average Price by Region (2025-2030) & (US$/Unit)
Table 103. Global Bacteria-derived Microbial Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 104. Global Bacteria-derived Microbial Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 105. Global Bacteria-derived Microbial Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 106. Global Bacteria-derived Microbial Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 107. Global Bacteria-derived Microbial Drugs Average Price by Type (2019-2024) & (US$/Unit)
Table 108. Global Bacteria-derived Microbial Drugs Average Price by Type (2025-2030) & (US$/Unit)
Table 109. Global Bacteria-derived Microbial Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 110. Global Bacteria-derived Microbial Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 111. Global Bacteria-derived Microbial Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 112. Global Bacteria-derived Microbial Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 113. Global Bacteria-derived Microbial Drugs Average Price by Application (2019-2024) & (US$/Unit)
Table 114. Global Bacteria-derived Microbial Drugs Average Price by Application (2025-2030) & (US$/Unit)
Table 115. North America Bacteria-derived Microbial Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 116. North America Bacteria-derived Microbial Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 117. North America Bacteria-derived Microbial Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 118. North America Bacteria-derived Microbial Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 119. North America Bacteria-derived Microbial Drugs Sales Quantity by Country (2019-2024) & (K Units)
Table 120. North America Bacteria-derived Microbial Drugs Sales Quantity by Country (2025-2030) & (K Units)
Table 121. North America Bacteria-derived Microbial Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 122. North America Bacteria-derived Microbial Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 123. Europe Bacteria-derived Microbial Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 124. Europe Bacteria-derived Microbial Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 125. Europe Bacteria-derived Microbial Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 126. Europe Bacteria-derived Microbial Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 127. Europe Bacteria-derived Microbial Drugs Sales Quantity by Country (2019-2024) & (K Units)
Table 128. Europe Bacteria-derived Microbial Drugs Sales Quantity by Country (2025-2030) & (K Units)
Table 129. Europe Bacteria-derived Microbial Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 130. Europe Bacteria-derived Microbial Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 131. Asia-Pacific Bacteria-derived Microbial Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 132. Asia-Pacific Bacteria-derived Microbial Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 133. Asia-Pacific Bacteria-derived Microbial Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 134. Asia-Pacific Bacteria-derived Microbial Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 135. Asia-Pacific Bacteria-derived Microbial Drugs Sales Quantity by Region (2019-2024) & (K Units)
Table 136. Asia-Pacific Bacteria-derived Microbial Drugs Sales Quantity by Region (2025-2030) & (K Units)
Table 137. Asia-Pacific Bacteria-derived Microbial Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 138. Asia-Pacific Bacteria-derived Microbial Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 139. South America Bacteria-derived Microbial Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 140. South America Bacteria-derived Microbial Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 141. South America Bacteria-derived Microbial Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 142. South America Bacteria-derived Microbial Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 143. South America Bacteria-derived Microbial Drugs Sales Quantity by Country (2019-2024) & (K Units)
Table 144. South America Bacteria-derived Microbial Drugs Sales Quantity by Country (2025-2030) & (K Units)
Table 145. South America Bacteria-derived Microbial Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 146. South America Bacteria-derived Microbial Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 147. Middle East & Africa Bacteria-derived Microbial Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 148. Middle East & Africa Bacteria-derived Microbial Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 149. Middle East & Africa Bacteria-derived Microbial Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 150. Middle East & Africa Bacteria-derived Microbial Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 151. Middle East & Africa Bacteria-derived Microbial Drugs Sales Quantity by Region (2019-2024) & (K Units)
Table 152. Middle East & Africa Bacteria-derived Microbial Drugs Sales Quantity by Region (2025-2030) & (K Units)
Table 153. Middle East & Africa Bacteria-derived Microbial Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 154. Middle East & Africa Bacteria-derived Microbial Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 155. Bacteria-derived Microbial Drugs Raw Material
Table 156. Key Manufacturers of Bacteria-derived Microbial Drugs Raw Materials
Table 157. Bacteria-derived Microbial Drugs Typical Distributors
Table 158. Bacteria-derived Microbial Drugs Typical Customers

LIST OF FIGURES

Figure 1. Bacteria-derived Microbial Drugs Picture
Figure 2. Global Bacteria-derived Microbial Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Bacteria-derived Microbial Drugs Consumption Value Market Share by Type in 2023
Figure 4. Oral Dosage Form Examples
Figure 5. Enteric Capsules Examples
Figure 6. Global Bacteria-derived Microbial Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Bacteria-derived Microbial Drugs Consumption Value Market Share by Application in 2023
Figure 8. Gastrointestinal Disorders Examples
Figure 9. Autoimmune Disorders Examples
Figure 10. Diabetes Examples
Figure 11. Cancer Examples
Figure 12. Others Examples
Figure 13. Global Bacteria-derived Microbial Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Bacteria-derived Microbial Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Bacteria-derived Microbial Drugs Sales Quantity (2019-2030) & (K Units)
Figure 16. Global Bacteria-derived Microbial Drugs Average Price (2019-2030) & (US$/Unit)
Figure 17. Global Bacteria-derived Microbial Drugs Sales Quantity Market Share by Manufacturer in 2023
Figure 18. Global Bacteria-derived Microbial Drugs Consumption Value Market Share by Manufacturer in 2023
Figure 19. Producer Shipments of Bacteria-derived Microbial Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 20. Top 3 Bacteria-derived Microbial Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Top 6 Bacteria-derived Microbial Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Global Bacteria-derived Microbial Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 23. Global Bacteria-derived Microbial Drugs Consumption Value Market Share by Region (2019-2030)
Figure 24. North America Bacteria-derived Microbial Drugs Consumption Value (2019-2030) & (USD Million)
Figure 25. Europe Bacteria-derived Microbial Drugs Consumption Value (2019-2030) & (USD Million)
Figure 26. Asia-Pacific Bacteria-derived Microbial Drugs Consumption Value (2019-2030) & (USD Million)
Figure 27. South America Bacteria-derived Microbial Drugs Consumption Value (2019-2030) & (USD Million)
Figure 28. Middle East & Africa Bacteria-derived Microbial Drugs Consumption Value (2019-2030) & (USD Million)
Figure 29. Global Bacteria-derived Microbial Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 30. Global Bacteria-derived Microbial Drugs Consumption Value Market Share by Type (2019-2030)
Figure 31. Global Bacteria-derived Microbial Drugs Average Price by Type (2019-2030) & (US$/Unit)
Figure 32. Global Bacteria-derived Microbial Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 33. Global Bacteria-derived Microbial Drugs Consumption Value Market Share by Application (2019-2030)
Figure 34. Global Bacteria-derived Microbial Drugs Average Price by Application (2019-2030) & (US$/Unit)
Figure 35. North America Bacteria-derived Microbial Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 36. North America Bacteria-derived Microbial Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 37. North America Bacteria-derived Microbial Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 38. North America Bacteria-derived Microbial Drugs Consumption Value Market Share by Country (2019-2030)
Figure 39. United States Bacteria-derived Microbial Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Canada Bacteria-derived Microbial Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Mexico Bacteria-derived Microbial Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Europe Bacteria-derived Microbial Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 43. Europe Bacteria-derived Microbial Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 44. Europe Bacteria-derived Microbial Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 45. Europe Bacteria-derived Microbial Drugs Consumption Value Market Share by Country (2019-2030)
Figure 46. Germany Bacteria-derived Microbial Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. France Bacteria-derived Microbial Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. United Kingdom Bacteria-derived Microbial Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Russia Bacteria-derived Microbial Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Italy Bacteria-derived Microbial Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Asia-Pacific Bacteria-derived Microbial Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 52. Asia-Pacific Bacteria-derived Microbial Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 53. Asia-Pacific Bacteria-derived Microbial Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 54. Asia-Pacific Bacteria-derived Microbial Drugs Consumption Value Market Share by Region (2019-2030)
Figure 55. China Bacteria-derived Microbial Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Japan Bacteria-derived Microbial Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Korea Bacteria-derived Microbial Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. India Bacteria-derived Microbial Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Southeast Asia Bacteria-derived Microbial Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Australia Bacteria-derived Microbial Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. South America Bacteria-derived Microbial Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 62. South America Bacteria-derived Microbial Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 63. South America Bacteria-derived Microbial Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 64. South America Bacteria-derived Microbial Drugs Consumption Value Market Share by Country (2019-2030)
Figure 65. Brazil Bacteria-derived Microbial Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Argentina Bacteria-derived Microbial Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Middle East & Africa Bacteria-derived Microbial Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 68. Middle East & Africa Bacteria-derived Microbial Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 69. Middle East & Africa Bacteria-derived Microbial Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 70. Middle East & Africa Bacteria-derived Microbial Drugs Consumption Value Market Share by Region (2019-2030)
Figure 71. Turkey Bacteria-derived Microbial Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Egypt Bacteria-derived Microbial Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Saudi Arabia Bacteria-derived Microbial Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. South Africa Bacteria-derived Microbial Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Bacteria-derived Microbial Drugs Market Drivers
Figure 76. Bacteria-derived Microbial Drugs Market Restraints
Figure 77. Bacteria-derived Microbial Drugs Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Bacteria-derived Microbial Drugs in 2023
Figure 80. Manufacturing Process Analysis of Bacteria-derived Microbial Drugs
Figure 81. Bacteria-derived Microbial Drugs Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source


More Publications